Ablative Solutions Lands $8 Million for Renal Denervation Tech

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ablative Solutions says it's pulled in an $8 million funding round for its perivascular renal denervation technology for treating high blood pressure. Ablative Solutions, which is developing perivascular renal denervation technology for treating high blood pressure, raised an $8.0 million funding round, according to a regulatory filing. Menlo Park, Calif.-based Ablative Solutions said 98 unnamed investors participated in the funding round, which consisted of debt, options and warrants.

Help employers find you! Check out all the jobs and post your resume.

Back to news